Cypress Capital Group’s Astera Labs ALAB Stock Holding History

Cypress Capital Group’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.43M	Buy	+5,026	New	+$1.33M	0.23%	91

Other funds holding ALAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cypress Capital Group's ALAB Position: Q2 2026 in Review

Cypress Capital Group opened a new position in Astera Labs (ALAB) in Q2 2026: 5,026 shares worth $2.43M. The stake represents 0.23% of the portfolio and ranks #91 among its holdings.

661 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Cypress Capital Group held 5,026 shares of Astera Labs worth $2.43M as of Q2 2026.
Astera Labs was a new Cypress Capital Group position in Q2 2026.
Astera Labs made up 0.23% of Cypress Capital Group's portfolio in Q2 2026, its #91 holding.
661 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Cypress Capital Group's 13F filing for Q2 2026, filed 5 Aug 2026.